Skip to content
X-twitter-square
Linkedin
Instagram
Facebook-square
Youtube
NASDAQ:
HELP |
CBOE CA:
HELP
Our Work
Clinical Trials
Development Pipeline
HLP003
HLP004
Intellectual Property
EMBARK
Scientific Publications
Investors
Overview
News
Events & Presentations
Financials
Governance
About Us
Our Team
Our Focus
Join Us
Contact Us
Our Work
Clinical Trials
Development Pipeline
HLP003
HLP004
Intellectual Property
EMBARK
Scientific Publications
Investors
Overview
News
Events & Presentations
Financials
Governance
About Us
Our Team
Our Focus
Join Us
Contact Us
Cybin Announces Additional U.S. Patent Supporting its CYB004 Program in Phase 2 Development for Generalized Anxiety Disorder
